Primary breast cancer
The purpose of this study was to identify genes that marks and mediates breast cancer metastasis to the lungs.
--
A cohort of 82 breast cancer patients treated at the Memorial Sloan-Kettering Cancer Center, New York was used in a univariate Cox proportional hazards model to relate the ...
--
--
For the primary breast tumour data, tissues from primary breast cancers were obtained from therapeutic procedures performed as part of routine clinical management. Samples ...
Minn, Andy J., Gaorav P. Gupta, Peter M. Siegel, Paula D. Bos, Weiping Shu, Dilip D. Giri, Agnes Viale, Adam B. Olshen, William L. Gerald, and Joan Massagué. “Genes That ...
Sample ID | series | IMS | IBS | IDS | ICR |
---|---|---|---|---|---|
GSM50034 | NA | Her2 | IBD | WID | ICR3 |
GSM50035 | NA | Basal | IBE | WID | ICR2 |
GSM50036 | NA | LumA | IBD | FID | ICR3 |
GSM50037 | NA | LumB | IBE | PID | ICR1 |
GSM50038 | NA | LumB | IBD | WID | ICR2 |
All fields are editable except the "Sample ID" column. To edit a cell, click within the cell. To edit a "date" cell, click on the calendar icon. To cancel an edit, press the ESC key.
Sample ID | Series | IMS | IBS | IDS | ICR | Array Sample ID | Sample Title | DMFS 10Y EVENT | DMFS 10Y TIME | Disease Free Survival Event | Distant Met Free Survival Event | Distant Met Free Survival | Age At Initial Pathologic Diagnosis | Lymph Node Status | ER Status | PR Status | Histology Differentiation Grade | Tumor Size Cm | Pathology T Stage | Bone Metastasis Event | Disease Free Survival Years | Lung Metastasis Event | Lymph Node Examined Count | RFS 5Y EVENT | Bone Metastasis Free Survival Years | HER2 IHC | Lung Metastasis Free Survival Years | Number Of Lymph Nodes Positive | Van T Veer Signature |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
GSM50034 | NA |
Her2 |
IBD |
WID |
ICR3 |
400003089 |
B110-T |
DistantMetastasisFree |
7.25 |
DiseaseFree |
NA |
NA |
61 |
NA |
ER- |
PR- |
NA |
2.2 |
T2 |
BoneMetastasisFree |
7.25 |
LungMetastasisFree |
11 |
0 |
7.25 |
3+ |
7.25 |
2 |
Good Prognosis |
GSM50035 | NA |
Basal |
IBE |
WID |
ICR2 |
400003090 |
B114-T |
DistantMetastasis |
1.84 |
Recurred/Progressed |
NA |
NA |
61 |
NA |
ER- |
PR- |
NA |
3.8 |
T2 |
BoneMetastasisFree |
1.84 |
LungMetastasis |
19 |
1 |
1.84 |
N |
1.84 |
3 |
Bad Prognosis |
GSM50036 | NA |
LumA |
IBD |
FID |
ICR3 |
400003091 |
B52-T |
DistantMetastasisFree |
9.15 |
DiseaseFree |
NA |
NA |
40 |
NA |
ER+ |
PR+ |
NA |
3 |
T2 |
BoneMetastasisFree |
9.15 |
LungMetastasisFree |
19 |
0 |
9.15 |
N |
9.15 |
0 |
Bad Prognosis |
GSM50037 | NA |
LumB |
IBE |
PID |
ICR1 |
400003092 |
B54-T |
DistantMetastasisFree |
6.86 |
DiseaseFree |
NA |
NA |
40 |
NA |
ER+ |
PR+ |
NA |
2.8 |
T2 |
BoneMetastasisFree |
6.86 |
LungMetastasisFree |
26 |
0 |
6.86 |
NA |
6.86 |
0 |
Good Prognosis |
GSM50038 | NA |
LumB |
IBD |
WID |
ICR2 |
400003093 |
B55-T |
DistantMetastasisFree |
6.47 |
DiseaseFree |
NA |
NA |
75 |
NA |
ER+ |
PR- |
NA |
2.2 |
T2 |
BoneMetastasisFree |
6.47 |
LungMetastasisFree |
15 |
0 |
6.47 |
1+ |
6.47 |
0 |
Good Prognosis |
GSM50039 | NA |
LumB |
IBE |
FID |
ICR4 |
400003094 |
B56-T |
DistantMetastasisFree |
7.08 |
DiseaseFree |
NA |
NA |
55 |
NA |
ER+ |
PR+ |
NA |
2.1 |
T2 |
BoneMetastasisFree |
7.08 |
LungMetastasisFree |
19 |
0 |
7.08 |
N |
7.08 |
0 |
Good Prognosis |
GSM50040 | NA |
Basal |
IBE |
WID |
ICR2 |
400003095 |
B57-T |
DistantMetastasisFree |
7.57 |
DiseaseFree |
NA |
NA |
57 |
NA |
ER- |
PR- |
NA |
2.8 |
T2 |
BoneMetastasisFree |
7.57 |
LungMetastasisFree |
19 |
0 |
7.57 |
N |
7.57 |
0 |
Bad Prognosis |
GSM50041 | NA |
NA |
NA |
NA |
NA |
400003096 |
B59-T |
NA |
NA |
NA |
NA |
NA |
73 |
NA |
ER- |
NA |
NA |
3.5 |
T2 |
NA |
NA |
NA |
9 |
NA |
NA |
NA |
NA |
0 |
NA |
GSM50042 | NA |
Basal |
IBE |
PID |
ICR3 |
400003097 |
B61-T |
DistantMetastasisFree |
4.41 |
DiseaseFree |
NA |
NA |
73 |
NA |
ER- |
PR- |
NA |
3.5 |
T2 |
BoneMetastasisFree |
4.41 |
LungMetastasisFree |
35 |
NA |
4.41 |
N |
4.41 |
0 |
Bad Prognosis |
GSM50043 | NA |
LumB |
IBE |
PID |
ICR1 |
400003098 |
B62-T |
DistantMetastasisFree |
5.23 |
DiseaseFree |
NA |
NA |
63 |
NA |
ER+ |
PR- |
NA |
5 |
T2 |
BoneMetastasisFree |
5.23 |
LungMetastasisFree |
15 |
0 |
5.23 |
1+ |
5.23 |
0 |
Good Prognosis |
GSM50044 | NA |
LumB |
IBD |
PID |
ICR1 |
400003099 |
B63-T |
DistantMetastasisFree |
5.62 |
DiseaseFree |
NA |
NA |
64 |
NA |
ER+ |
PR- |
NA |
3.2 |
T2 |
BoneMetastasisFree |
5.62 |
LungMetastasisFree |
27 |
0 |
5.62 |
N |
5.62 |
0 |
Good Prognosis |
GSM50045 | NA |
ClaudinLow |
IBD |
PID |
ICR1 |
400003100 |
B66-T |
DistantMetastasisFree |
10 |
DiseaseFree |
NA |
NA |
58 |
NA |
ER- |
PR- |
NA |
2.8 |
T2 |
BoneMetastasisFree |
10.75 |
LungMetastasisFree |
31 |
0 |
10.75 |
NA |
10.75 |
0 |
Bad Prognosis |
GSM50046 | NA |
Basal |
IBE |
FID |
ICR4 |
400003101 |
B67-T |
DistantMetastasisFree |
8.04 |
DiseaseFree |
NA |
NA |
32 |
NA |
ER- |
PR- |
NA |
1.8 |
T1c |
BoneMetastasisFree |
8.04 |
LungMetastasisFree |
18 |
0 |
8.04 |
N |
8.04 |
0 |
Bad Prognosis |
GSM50047 | NA |
LumA |
IBD |
WID |
ICR2 |
400003102 |
B68-T |
DistantMetastasisFree |
5.41 |
DiseaseFree |
NA |
NA |
86 |
NA |
ER+ |
PR+ |
NA |
3.2 |
T2 |
BoneMetastasisFree |
5.41 |
LungMetastasisFree |
18 |
0 |
5.41 |
N |
5.41 |
0 |
Bad Prognosis |
GSM50048 | NA |
Basal |
IBE |
PID |
ICR1 |
400003103 |
B69-T |
DistantMetastasisFree |
6.07 |
DiseaseFree |
NA |
NA |
49 |
NA |
ER- |
PR- |
NA |
1.5 |
T1c |
BoneMetastasisFree |
6.07 |
LungMetastasisFree |
6 |
0 |
6.07 |
N |
6.07 |
0 |
Bad Prognosis |
GSM50049 | NA |
LumA |
IBD |
PID |
ICR1 |
400003104 |
B71-T |
DistantMetastasisFree |
5.5 |
DiseaseFree |
NA |
NA |
46 |
NA |
ER+ |
PR+ |
NA |
2.1 |
T2 |
BoneMetastasisFree |
5.5 |
LungMetastasisFree |
18 |
0 |
5.5 |
N |
5.5 |
0 |
Good Prognosis |
GSM50050 | NA |
NA |
NA |
NA |
NA |
400003105 |
B72-T |
NA |
NA |
NA |
NA |
NA |
63 |
NA |
ER- |
PR- |
NA |
1.1 |
T1c |
NA |
NA |
NA |
18 |
NA |
NA |
NA |
NA |
0 |
NA |
GSM50051 | NA |
LumA |
IBD |
WID |
ICR2 |
400003106 |
B74-T |
DistantMetastasisFree |
3.77 |
DiseaseFree |
NA |
NA |
49 |
NA |
ER+ |
PR+ |
NA |
6 |
T3/T4 |
BoneMetastasisFree |
3.77 |
LungMetastasisFree |
21 |
NA |
3.77 |
N |
3.77 |
0 |
Good Prognosis |
GSM50052 | NA |
Basal |
IBE |
WID |
ICR3 |
400003107 |
B75-T |
DistantMetastasisFree |
4.56 |
DiseaseFree |
NA |
NA |
47 |
NA |
ER- |
PR- |
NA |
5 |
T2 |
BoneMetastasisFree |
4.56 |
LungMetastasisFree |
8 |
NA |
4.56 |
0-1 |
4.56 |
0 |
Bad Prognosis |
GSM50053 | NA |
LumA |
IBD |
WID |
ICR2 |
400003108 |
B76-T |
DistantMetastasisFree |
3.97 |
DiseaseFree |
NA |
NA |
82 |
NA |
ER+ |
PR+ |
NA |
2 |
T1c |
BoneMetastasisFree |
3.97 |
LungMetastasisFree |
3 |
NA |
3.97 |
N |
3.97 |
0 |
Bad Prognosis |
GSM50054 | NA |
ClaudinLow |
IBD |
WID |
ICR3 |
400003109 |
B77-T |
DistantMetastasisFree |
4.05 |
DiseaseFree |
NA |
NA |
73 |
NA |
ER- |
PR- |
NA |
3 |
T2 |
BoneMetastasisFree |
4.05 |
LungMetastasisFree |
16 |
NA |
4.05 |
0-1 |
4.05 |
0 |
Bad Prognosis |
GSM50055 | NA |
NA |
NA |
NA |
NA |
400003110 |
B53-T |
NA |
NA |
NA |
NA |
NA |
33 |
NA |
ER- |
PR- |
NA |
3.5 |
T2 |
NA |
NA |
NA |
15 |
NA |
NA |
0-1 |
NA |
0 |
NA |
GSM50056 | NA |
NA |
NA |
NA |
NA |
400003111 |
B58-T |
NA |
NA |
NA |
NA |
NA |
70 |
NA |
ER+ |
PR- |
NA |
5 |
T2 |
NA |
NA |
NA |
26 |
NA |
NA |
NA |
NA |
0 |
NA |
GSM50057 | NA |
NA |
NA |
NA |
NA |
400003112 |
B60-T |
NA |
NA |
NA |
NA |
NA |
46 |
NA |
ER- |
PR- |
NA |
4 |
T2 |
NA |
NA |
NA |
39 |
NA |
NA |
3+ |
NA |
0 |
NA |
GSM50058 | NA |
NA |
NA |
NA |
NA |
400003113 |
B70-T |
NA |
NA |
NA |
NA |
NA |
51 |
NA |
ER- |
PR- |
NA |
4 |
T2 |
NA |
NA |
NA |
16 |
NA |
NA |
2+ |
NA |
0 |
NA |
GSM50059 | NA |
LumB |
IBD |
PID |
ICR3 |
400003114 |
B42-T |
DistantMetastasisFree |
7.63 |
DiseaseFree |
NA |
NA |
73 |
NA |
ER+ |
PR+ |
NA |
2.9 |
T2 |
BoneMetastasisFree |
7.63 |
LungMetastasisFree |
16 |
0 |
7.63 |
N |
7.63 |
0 |
Good Prognosis |
GSM50060 | NA |
Her2 |
IBE |
PID |
ICR1 |
400003115 |
B43-T |
DistantMetastasis |
3.47 |
Recurred/Progressed |
NA |
NA |
52 |
NA |
ER- |
PR- |
NA |
4.5 |
T2 |
BoneMetastasisFree |
3.47 |
LungMetastasis |
26 |
1 |
4.62 |
1+ |
3.47 |
0 |
Bad Prognosis |
GSM50061 | NA |
ClaudinLow |
IBD |
WID |
ICR3 |
400003116 |
B44-T |
DistantMetastasis |
3.96 |
Recurred/Progressed |
NA |
NA |
61 |
NA |
ER- |
PR- |
NA |
6 |
T3/T4 |
BoneMetastasis |
3.96 |
LungMetastasis |
26 |
1 |
3.96 |
N |
3.96 |
0 |
Good Prognosis |
GSM50062 | NA |
LumB |
IBE |
PID |
ICR1 |
400003117 |
B45-T |
DistantMetastasis |
3.07 |
Recurred/Progressed |
NA |
NA |
68 |
NA |
ER+ |
PR+ |
NA |
3.5 |
T2 |
BoneMetastasisFree |
3.07 |
LungMetastasisFree |
23 |
1 |
6.17 |
N |
6.17 |
0 |
Good Prognosis |
GSM50063 | NA |
ClaudinLow |
IBD |
PID |
ICR1 |
400003118 |
B46-T |
DistantMetastasis |
3.11 |
Recurred/Progressed |
NA |
NA |
49 |
NA |
ER- |
PR- |
NA |
3.2 |
T2 |
BoneMetastasisFree |
3.11 |
LungMetastasis |
36 |
1 |
5.71 |
N |
3.11 |
0 |
Bad Prognosis |
GSM50064 | NA |
Normal |
IBE |
NA |
ICR3 |
400003119 |
B47-T |
DistantMetastasis |
0.94 |
Recurred/Progressed |
NA |
NA |
70 |
NA |
ER- |
PR- |
NA |
6.5 |
T3/T4 |
BoneMetastasis |
0.94 |
LungMetastasis |
14 |
1 |
0.94 |
N |
1.34 |
0 |
Bad Prognosis |
GSM50065 | NA |
Her2 |
IBD |
WID |
ICR3 |
400003120 |
B48-T |
DistantMetastasisFree |
5.81 |
DiseaseFree |
NA |
NA |
54 |
NA |
ER+ |
PR- |
NA |
3 |
T2 |
BoneMetastasisFree |
5.81 |
LungMetastasisFree |
11 |
0 |
5.81 |
3+ |
5.81 |
0 |
Bad Prognosis |
GSM50066 | NA |
ClaudinLow |
IBD |
WID |
ICR3 |
400003121 |
B49-T |
DistantMetastasis |
1.24 |
Recurred/Progressed |
NA |
NA |
80 |
NA |
ER- |
PR- |
NA |
2 |
T1c |
BoneMetastasis |
1.24 |
LungMetastasis |
4 |
1 |
1.24 |
N |
1.24 |
0 |
Bad Prognosis |
GSM50067 | NA |
Basal |
IBE |
PID |
ICR2 |
400003122 |
B50-T |
DistantMetastasis |
0.77 |
Recurred/Progressed |
NA |
NA |
78 |
NA |
ER- |
PR- |
NA |
3 |
T2 |
BoneMetastasisFree |
0.77 |
LungMetastasis |
2 |
1 |
0.95 |
N |
0.77 |
0 |
Bad Prognosis |
GSM50068 | NA |
LumA |
IBD |
WID |
ICR2 |
400003123 |
B51-T |
DistantMetastasis |
3.48 |
Recurred/Progressed |
NA |
NA |
57 |
NA |
ER+ |
PR- |
NA |
1.7 |
T1c |
BoneMetastasisFree |
3.48 |
LungMetastasis |
17 |
1 |
6.01 |
N |
3.48 |
0 |
Bad Prognosis |
GSM50069 | NA |
Basal |
IBD |
PID |
ICR2 |
400003124 |
B73-T |
DistantMetastasis |
3.83 |
Recurred/Progressed |
NA |
NA |
73 |
NA |
ER- |
PR- |
NA |
3.2 |
T2 |
BoneMetastasisFree |
3.83 |
LungMetastasis |
17 |
1 |
4.01 |
N |
3.83 |
0 |
Bad Prognosis |
GSM50070 | NA |
Her2 |
IBD |
FID |
ICR4 |
400003125 |
B98-T |
DistantMetastasis |
3.36 |
Recurred/Progressed |
NA |
NA |
58 |
NA |
ER- |
PR- |
NA |
2 |
T1c |
BoneMetastasis |
3.36 |
LungMetastasisFree |
16 |
1 |
3.36 |
N |
6.96 |
3 |
Bad Prognosis |
GSM50071 | NA |
Her2 |
IBD |
FID |
ICR3 |
400003126 |
B100-T |
DistantMetastasisFree |
5.82 |
DiseaseFree |
NA |
NA |
78 |
NA |
ER- |
PR- |
NA |
2.5 |
T2 |
BoneMetastasisFree |
5.82 |
LungMetastasisFree |
14 |
0 |
5.82 |
N |
5.82 |
2 |
Bad Prognosis |
GSM50072 | NA |
Basal |
IBE |
FID |
ICR4 |
400003127 |
B101-T |
DistantMetastasisFree |
10 |
DiseaseFree |
NA |
NA |
47 |
NA |
ER- |
PR- |
NA |
3.5 |
T2 |
BoneMetastasisFree |
10.74 |
LungMetastasisFree |
26 |
0 |
10.74 |
3+ |
10.74 |
2 |
Bad Prognosis |
GSM50073 | NA |
Basal |
IBE |
FID |
ICR4 |
400003128 |
B102-T |
DistantMetastasisFree |
7.25 |
DiseaseFree |
NA |
NA |
50 |
NA |
ER- |
PR- |
NA |
4 |
T2 |
BoneMetastasisFree |
7.25 |
LungMetastasisFree |
29 |
0 |
7.25 |
N |
7.25 |
2 |
Bad Prognosis |
GSM50074 | NA |
LumA |
IBD |
WID |
ICR1 |
400003129 |
B104-T |
DistantMetastasisFree |
7.32 |
DiseaseFree |
NA |
NA |
49 |
NA |
ER+ |
PR- |
NA |
2.95 |
T2 |
BoneMetastasisFree |
7.32 |
LungMetastasisFree |
19 |
0 |
7.32 |
N |
7.32 |
3 |
Good Prognosis |
GSM50075 | NA |
ClaudinLow |
IBD |
WID |
ICR2 |
400003130 |
B105-T |
DistantMetastasisFree |
7.32 |
DiseaseFree |
NA |
NA |
49 |
NA |
ER+ |
PR+ |
NA |
2.95 |
T2 |
BoneMetastasisFree |
7.32 |
LungMetastasisFree |
19 |
0 |
7.32 |
N |
7.32 |
3 |
Bad Prognosis |
GSM50076 | NA |
NA |
NA |
NA |
NA |
400003131 |
B106-T |
NA |
NA |
NA |
NA |
NA |
57 |
NA |
ER+ |
PR+ |
NA |
2.1 |
T2 |
NA |
NA |
NA |
16 |
NA |
NA |
N |
NA |
2 |
NA |
GSM50077 | NA |
NA |
NA |
NA |
NA |
400003132 |
B107-T |
NA |
NA |
NA |
NA |
NA |
57 |
NA |
ER+ |
PR+ |
NA |
2.1 |
T2 |
NA |
NA |
NA |
16 |
NA |
NA |
N |
NA |
2 |
NA |
GSM50078 | NA |
Basal |
IBE |
PID |
ICR1 |
400003133 |
B112-T |
DistantMetastasisFree |
6.98 |
DiseaseFree |
NA |
NA |
41 |
NA |
ER- |
PR+ |
NA |
4 |
T2 |
BoneMetastasisFree |
6.98 |
LungMetastasisFree |
20 |
0 |
6.98 |
N |
6.98 |
1 |
Bad Prognosis |
GSM50079 | NA |
Basal |
IBE |
WID |
ICR3 |
400003134 |
B115-T |
DistantMetastasisFree |
6.52 |
DiseaseFree |
NA |
NA |
40 |
NA |
ER- |
PR- |
NA |
5 |
T2 |
BoneMetastasisFree |
6.52 |
LungMetastasisFree |
16 |
0 |
6.52 |
N |
6.52 |
3 |
Bad Prognosis |
GSM50080 | NA |
LumA |
IBD |
PID |
ICR1 |
400003135 |
B78-T |
DistantMetastasisFree |
7.25 |
DiseaseFree |
NA |
NA |
41 |
NA |
ER+ |
PR+ |
NA |
2 |
T1c |
BoneMetastasisFree |
7.25 |
LungMetastasisFree |
28 |
0 |
7.25 |
N |
7.25 |
2 |
Good Prognosis |
GSM50081 | NA |
LumA |
IBD |
PID |
ICR2 |
400003136 |
B79-T |
DistantMetastasisFree |
5.07 |
DiseaseFree |
NA |
NA |
81 |
NA |
ER+ |
PR+ |
NA |
2.4 |
T2 |
BoneMetastasisFree |
5.07 |
LungMetastasisFree |
12 |
0 |
5.07 |
NA |
5.07 |
1 |
Good Prognosis |
GSM50082 | NA |
Normal |
IBE |
NA |
ICR1 |
400003137 |
B80-T |
DistantMetastasisFree |
7.11 |
DiseaseFree |
NA |
NA |
49 |
NA |
ER+ |
PR+ |
NA |
2.2 |
T2 |
BoneMetastasisFree |
7.11 |
LungMetastasisFree |
37 |
0 |
7.11 |
2+ |
7.11 |
3 |
Good Prognosis |
GSM50083 | NA |
LumA |
IBD |
PID |
ICR2 |
400003138 |
B82-T |
DistantMetastasisFree |
7.28 |
DiseaseFree |
NA |
NA |
61 |
NA |
ER+ |
PR+ |
NA |
2.5 |
T2 |
BoneMetastasisFree |
7.28 |
LungMetastasisFree |
21 |
0 |
7.28 |
N |
7.28 |
1 |
Good Prognosis |
GSM50084 | NA |
Normal |
IBE |
NA |
ICR2 |
400003139 |
B83-T |
DistantMetastasisFree |
6.4 |
DiseaseFree |
NA |
NA |
39 |
NA |
ER+ |
PR+ |
NA |
4 |
T2 |
BoneMetastasisFree |
6.4 |
LungMetastasisFree |
23 |
0 |
6.4 |
1+ |
6.4 |
1 |
Good Prognosis |
GSM50085 | NA |
LumB |
IBE |
PID |
ICR2 |
400003140 |
B84-T |
DistantMetastasisFree |
6.5 |
DiseaseFree |
NA |
NA |
37 |
NA |
ER+ |
PR+ |
NA |
2.3 |
T2 |
BoneMetastasisFree |
6.5 |
LungMetastasisFree |
22 |
0 |
6.5 |
2+ |
6.5 |
3 |
Good Prognosis |
GSM50086 | NA |
Her2 |
IBE |
WID |
ICR4 |
400003141 |
B85-T |
DistantMetastasisFree |
8.31 |
DiseaseFree |
NA |
NA |
57 |
NA |
ER+ |
PR- |
NA |
4.3 |
T2 |
BoneMetastasisFree |
8.31 |
LungMetastasisFree |
18 |
0 |
8.31 |
N |
8.31 |
1 |
Good Prognosis |
GSM50087 | NA |
LumB |
IBD |
FID |
ICR3 |
400003142 |
B86-T |
DistantMetastasisFree |
8.31 |
DiseaseFree |
NA |
NA |
57 |
NA |
ER+ |
PR- |
NA |
4.3 |
T2 |
BoneMetastasisFree |
8.31 |
LungMetastasisFree |
18 |
0 |
8.31 |
N |
8.31 |
1 |
Good Prognosis |
GSM50088 | NA |
NA |
NA |
NA |
NA |
400003143 |
B87-T |
NA |
NA |
NA |
NA |
NA |
51 |
NA |
ER+ |
PR- |
NA |
2.5 |
T2 |
NA |
NA |
NA |
17 |
NA |
NA |
3+ |
NA |
1 |
NA |
GSM50089 | NA |
Normal |
IBE |
NA |
ICR2 |
400003144 |
B89-T |
DistantMetastasisFree |
8.74 |
DiseaseFree |
NA |
NA |
30 |
NA |
ER- |
PR- |
NA |
3 |
T2 |
BoneMetastasisFree |
8.74 |
LungMetastasisFree |
30 |
0 |
8.74 |
N |
8.74 |
3 |
Good Prognosis |
GSM50090 | NA |
LumA |
IBD |
PID |
ICR1 |
400003145 |
B90-T |
DistantMetastasisFree |
6.79 |
DiseaseFree |
NA |
NA |
34 |
NA |
ER+ |
PR+ |
NA |
4.3 |
T2 |
BoneMetastasisFree |
6.79 |
LungMetastasisFree |
21 |
0 |
6.79 |
NA |
6.79 |
1 |
Good Prognosis |
GSM50091 | NA |
LumB |
IBE |
WID |
ICR4 |
400003146 |
B91-T |
DistantMetastasisFree |
7.19 |
DiseaseFree |
NA |
NA |
84 |
NA |
ER+ |
PR- |
NA |
10 |
T3/T4 |
BoneMetastasisFree |
7.19 |
LungMetastasisFree |
11 |
0 |
7.19 |
N |
7.19 |
2 |
Good Prognosis |
GSM50092 | NA |
Her2 |
IBD |
WID |
ICR4 |
400003147 |
B93-T |
DistantMetastasisFree |
6.45 |
DiseaseFree |
NA |
NA |
50 |
NA |
ER- |
PR- |
NA |
2.3 |
T2 |
BoneMetastasisFree |
6.45 |
LungMetastasisFree |
29 |
0 |
6.45 |
N |
6.45 |
1 |
Bad Prognosis |
GSM50093 | NA |
Basal |
IBE |
FID |
ICR3 |
400003148 |
B97-T |
DistantMetastasisFree |
7.86 |
DiseaseFree |
NA |
NA |
64 |
NA |
ER- |
PR- |
NA |
2 |
T1c |
BoneMetastasisFree |
7.86 |
LungMetastasisFree |
20 |
0 |
7.86 |
N |
7.86 |
2 |
Bad Prognosis |
GSM50094 | NA |
Basal |
IBE |
PID |
ICR2 |
400003149 |
B103-T |
DistantMetastasis |
3.22 |
Recurred/Progressed |
NA |
NA |
57 |
NA |
ER- |
PR- |
NA |
1.3 |
T1c |
BoneMetastasis |
3.22 |
LungMetastasis |
15 |
1 |
3.65 |
N |
3.22 |
3 |
Bad Prognosis |
GSM50095 | NA |
LumA |
IBD |
WID |
ICR3 |
400003150 |
B108-T |
DistantMetastasis |
6.54 |
Recurred/Progressed |
NA |
NA |
54 |
NA |
ER+ |
PR+ |
NA |
2.6 |
T2 |
BoneMetastasisFree |
6.54 |
LungMetastasisFree |
29 |
0 |
7.46 |
N |
7.46 |
1 |
Good Prognosis |
GSM50096 | NA |
ClaudinLow |
IBD |
PID |
ICR2 |
400003151 |
B109-T |
DistantMetastasis |
1.38 |
Recurred/Progressed |
NA |
NA |
32 |
NA |
ER- |
PR- |
NA |
6 |
T3/T4 |
BoneMetastasisFree |
1.38 |
LungMetastasis |
32 |
1 |
1.67 |
N |
1.38 |
2 |
Bad Prognosis |
GSM50097 | NA |
LumB |
IBE |
PID |
ICR1 |
400003152 |
B111-T |
DistantMetastasis |
5.39 |
Recurred/Progressed |
NA |
NA |
46 |
NA |
ER+ |
PR+ |
NA |
1.3 |
T1c |
BoneMetastasis |
5.39 |
LungMetastasisFree |
22 |
0 |
5.39 |
N |
7.11 |
2 |
Good Prognosis |
GSM50098 | NA |
LumA |
IBD |
WID |
ICR2 |
400003153 |
B113-T |
DistantMetastasis |
2.57 |
Recurred/Progressed |
NA |
NA |
49 |
NA |
ER+ |
PR+ |
NA |
1.5 |
T1c |
BoneMetastasis |
2.57 |
LungMetastasisFree |
22 |
1 |
2.57 |
N |
7.53 |
3 |
Good Prognosis |
GSM50099 | NA |
LumA |
IBD |
WID |
ICR2 |
400003154 |
B81-T |
DistantMetastasis |
1.3 |
Recurred/Progressed |
NA |
NA |
31 |
NA |
ER+ |
PR+ |
NA |
2.5 |
T2 |
BoneMetastasis |
1.3 |
LungMetastasisFree |
10 |
1 |
1.3 |
NA |
5.68 |
5 |
Good Prognosis |
GSM50100 | NA |
LumA |
IBD |
PID |
ICR1 |
400003155 |
B88-T |
DistantMetastasis |
5.81 |
Recurred/Progressed |
NA |
NA |
61 |
NA |
ER+ |
PR+ |
NA |
4.8 |
T2 |
BoneMetastasisFree |
5.81 |
LungMetastasisFree |
15 |
0 |
7.96 |
N |
7.96 |
1 |
Good Prognosis |
GSM50101 | NA |
LumA |
IBD |
PID |
ICR2 |
400003156 |
B92-T |
DistantMetastasis |
6.36 |
Recurred/Progressed |
NA |
NA |
72 |
NA |
ER+ |
PR+ |
NA |
2.5 |
T2 |
BoneMetastasis |
6.36 |
LungMetastasisFree |
19 |
0 |
6.36 |
N |
7.58 |
3 |
Good Prognosis |
GSM50102 | NA |
Basal |
IBE |
PID |
ICR1 |
400003157 |
B94-T |
DistantMetastasis |
0.67 |
Recurred/Progressed |
NA |
NA |
48 |
NA |
ER- |
PR- |
NA |
4 |
T2 |
BoneMetastasisFree |
0.67 |
LungMetastasisFree |
18 |
1 |
1.03 |
N |
1.03 |
1 |
Bad Prognosis |
GSM50103 | NA |
Basal |
IBE |
PID |
ICR2 |
400003158 |
B95-T |
DistantMetastasis |
1.84 |
Recurred/Progressed |
NA |
NA |
61 |
NA |
ER- |
PR- |
NA |
3.8 |
T2 |
BoneMetastasisFree |
1.84 |
LungMetastasis |
19 |
1 |
1.84 |
3+ |
1.84 |
3 |
Bad Prognosis |
GSM50104 | NA |
Normal |
IBE |
NA |
ICR2 |
400003159 |
B96-T |
DistantMetastasis |
6.77 |
Recurred/Progressed |
NA |
NA |
65 |
NA |
ER+ |
PR+ |
NA |
2.9 |
T2 |
BoneMetastasis |
6.77 |
LungMetastasisFree |
18 |
0 |
6.77 |
N |
8.89 |
1 |
Good Prognosis |
GSM50105 | NA |
LumA |
IBD |
WID |
ICR3 |
400003160 |
B99-T |
DistantMetastasisFree |
7.19 |
DiseaseFree |
NA |
NA |
54 |
NA |
ER+ |
PR- |
NA |
4.5 |
T2 |
BoneMetastasisFree |
7.19 |
LungMetastasisFree |
19 |
0 |
7.19 |
NA |
7.19 |
1 |
Good Prognosis |
GSM50106 | NA |
ClaudinLow |
IBD |
WID |
ICR3 |
400003161 |
B7-T |
DistantMetastasis |
1.58 |
Recurred/Progressed |
NA |
NA |
60 |
NA |
ER- |
PR- |
NA |
10 |
T3/T4 |
BoneMetastasisFree |
1.58 |
LungMetastasis |
26 |
1 |
1.65 |
N |
1.58 |
15 |
Bad Prognosis |
GSM50107 | NA |
Basal |
IBE |
PID |
ICR2 |
400003162 |
B10-T |
DistantMetastasisFree |
6.21 |
DiseaseFree |
NA |
NA |
52 |
NA |
ER- |
PR- |
NA |
6.5 |
T3/T4 |
BoneMetastasisFree |
6.21 |
LungMetastasisFree |
9 |
0 |
6.21 |
N |
6.21 |
8 |
Bad Prognosis |
GSM50108 | NA |
LumA |
IBD |
WID |
ICR2 |
400003163 |
B11-T |
DistantMetastasisFree |
3.96 |
DiseaseFree |
NA |
NA |
52 |
NA |
ER+ |
PR+ |
NA |
1.8 |
T1c |
BoneMetastasisFree |
3.96 |
LungMetastasisFree |
33 |
NA |
3.96 |
N |
3.96 |
12 |
Good Prognosis |
GSM50109 | NA |
NA |
NA |
NA |
NA |
400003164 |
B12-T |
NA |
NA |
NA |
NA |
NA |
57 |
NA |
ER+ |
PR+ |
NA |
2 |
T1c |
NA |
NA |
NA |
21 |
NA |
NA |
NA |
NA |
1 |
NA |
GSM50110 | NA |
Basal |
IBE |
FID |
ICR4 |
400003165 |
B13-T |
DistantMetastasisFree |
5.19 |
DiseaseFree |
NA |
NA |
44 |
NA |
ER- |
PR- |
NA |
6.1 |
T3/T4 |
BoneMetastasisFree |
5.19 |
LungMetastasisFree |
15 |
0 |
5.19 |
N |
5.19 |
1 |
Bad Prognosis |
GSM50111 | NA |
LumA |
IBD |
PID |
ICR1 |
400003166 |
B14-T |
DistantMetastasisFree |
7.3 |
DiseaseFree |
NA |
NA |
61 |
NA |
ER+ |
PR+ |
NA |
5 |
T2 |
BoneMetastasisFree |
7.3 |
LungMetastasisFree |
33 |
0 |
7.3 |
N |
7.3 |
30 |
Good Prognosis |
GSM50112 | NA |
Basal |
IBE |
PID |
ICR2 |
400003167 |
B15-T |
DistantMetastasis |
1.18 |
Recurred/Progressed |
NA |
NA |
43 |
NA |
ER+ |
PR- |
NA |
4.5 |
T2 |
BoneMetastasis |
1.18 |
LungMetastasis |
21 |
1 |
1.18 |
N |
1.18 |
1 |
Bad Prognosis |
GSM50113 | NA |
NA |
NA |
NA |
NA |
400003168 |
B16-T |
NA |
NA |
NA |
NA |
NA |
56 |
NA |
ER+ |
PR+ |
NA |
2.6 |
T2 |
NA |
NA |
NA |
26 |
NA |
NA |
1+ |
NA |
5 |
NA |
GSM50114 | NA |
LumA |
IBD |
FID |
ICR3 |
400003169 |
B17-T |
DistantMetastasis |
1.3 |
Recurred/Progressed |
NA |
NA |
62 |
NA |
ER+ |
PR+ |
NA |
3.5 |
T2 |
BoneMetastasis |
1.3 |
LungMetastasisFree |
21 |
1 |
1.3 |
N |
1.3 |
20 |
Good Prognosis |
GSM50115 | NA |
LumA |
IBD |
WID |
ICR2 |
400003170 |
B18-T |
DistantMetastasisFree |
4.42 |
DiseaseFree |
NA |
NA |
40 |
NA |
ER+ |
PR+ |
NA |
3.5 |
T2 |
BoneMetastasisFree |
4.42 |
LungMetastasisFree |
26 |
NA |
4.42 |
N |
4.42 |
17 |
Good Prognosis |
GSM50116 | NA |
Normal |
IBE |
NA |
ICR2 |
400003171 |
B1-T |
DistantMetastasisFree |
3.58 |
DiseaseFree |
NA |
NA |
65 |
NA |
ER- |
PR- |
NA |
7.5 |
T3/T4 |
BoneMetastasisFree |
3.58 |
LungMetastasisFree |
19 |
NA |
3.58 |
2+ |
3.58 |
4 |
Bad Prognosis |
GSM50117 | NA |
NA |
NA |
NA |
NA |
400003172 |
B23-T |
NA |
NA |
NA |
NA |
NA |
38 |
NA |
ER+ |
PR+ |
NA |
1.5 |
T1c |
NA |
NA |
NA |
17 |
NA |
NA |
3+ |
NA |
17 |
NA |
GSM50118 | NA |
LumB |
IBD |
PID |
ICR3 |
400003173 |
B24-T |
DistantMetastasisFree |
6.28 |
DiseaseFree |
NA |
NA |
72 |
NA |
ER+ |
PR+ |
NA |
3 |
T2 |
BoneMetastasisFree |
6.28 |
LungMetastasisFree |
23 |
0 |
6.28 |
N |
6.28 |
5 |
Bad Prognosis |
GSM50119 | NA |
Basal |
IBE |
WID |
ICR3 |
400003174 |
B26-T |
DistantMetastasisFree |
4.18 |
DiseaseFree |
NA |
NA |
54 |
NA |
ER- |
PR- |
NA |
4 |
T2 |
BoneMetastasisFree |
4.18 |
LungMetastasisFree |
31 |
NA |
4.18 |
1+ |
4.18 |
7 |
Bad Prognosis |
GSM50120 | NA |
NA |
IBE |
NA |
ICR3 |
400003175 |
B27-T |
DistantMetastasisFree |
3.68 |
DiseaseFree |
NA |
NA |
38 |
NA |
ER+ |
PR+ |
NA |
4.1 |
T2 |
BoneMetastasisFree |
3.68 |
LungMetastasisFree |
31 |
NA |
3.68 |
N |
3.68 |
5 |
Bad Prognosis |
GSM50121 | NA |
LumA |
IBD |
PID |
ICR1 |
400003176 |
B28-T |
DistantMetastasisFree |
4.12 |
DiseaseFree |
NA |
NA |
54 |
NA |
ER+ |
PR+ |
NA |
6 |
T3/T4 |
BoneMetastasisFree |
4.12 |
LungMetastasisFree |
27 |
NA |
4.12 |
1+ |
4.12 |
6 |
Good Prognosis |
GSM50122 | NA |
LumB |
IBD |
FID |
ICR4 |
400003177 |
B29-T |
DistantMetastasis |
3.24 |
Recurred/Progressed |
NA |
NA |
43 |
NA |
ER+ |
PR+ |
NA |
8 |
T3/T4 |
BoneMetastasis |
3.24 |
LungMetastasisFree |
36 |
1 |
3.24 |
N |
4.07 |
22 |
Bad Prognosis |
GSM50123 | NA |
Basal |
IBE |
FID |
ICR4 |
400003178 |
B2-T |
DistantMetastasisFree |
3.9 |
DiseaseFree |
NA |
NA |
59 |
NA |
ER- |
PR- |
NA |
4.5 |
T2 |
BoneMetastasisFree |
3.9 |
LungMetastasisFree |
21 |
NA |
3.9 |
N |
3.9 |
10 |
Bad Prognosis |
GSM50124 | NA |
NA |
NA |
NA |
NA |
400003179 |
B31-T |
NA |
NA |
NA |
NA |
NA |
87 |
NA |
ER+ |
PR+ |
NA |
2.9 |
T2 |
NA |
NA |
NA |
20 |
NA |
NA |
N |
NA |
2 |
NA |
GSM50125 | NA |
NA |
NA |
NA |
NA |
400003180 |
B32-T |
NA |
NA |
NA |
NA |
NA |
59 |
NA |
ER- |
PR- |
NA |
7 |
T3/T4 |
NA |
NA |
NA |
17 |
NA |
NA |
1+ |
NA |
1 |
NA |
GSM50126 | NA |
NA |
NA |
NA |
NA |
400003181 |
B33-T |
NA |
NA |
NA |
NA |
NA |
38 |
NA |
ER+ |
PR+ |
NA |
3.5 |
T2 |
NA |
NA |
NA |
16 |
NA |
NA |
3+ |
NA |
2 |
NA |
GSM50127 | NA |
Her2 |
IBD |
WID |
ICR4 |
400003182 |
B3-T |
DistantMetastasisFree |
5.24 |
DiseaseFree |
NA |
NA |
59 |
NA |
ER+ |
PR+ |
NA |
6 |
T3/T4 |
BoneMetastasisFree |
5.24 |
LungMetastasisFree |
29 |
0 |
5.24 |
1+ (only 1 core pos.) |
5.24 |
4 |
Bad Prognosis |
GSM50128 | NA |
LumA |
IBD |
PID |
ICR2 |
400003183 |
B4-T |
DistantMetastasisFree |
2.3 |
DiseaseFree |
NA |
NA |
70 |
NA |
ER+ |
PR+ |
NA |
3 |
T2 |
BoneMetastasisFree |
2.3 |
LungMetastasisFree |
11 |
NA |
2.3 |
1+ |
2.3 |
6 |
Good Prognosis |
GSM50129 | NA |
NA |
NA |
NA |
NA |
400003184 |
B5-T |
NA |
NA |
NA |
NA |
NA |
39 |
NA |
ER+ |
PR- |
NA |
6 |
T3/T4 |
NA |
NA |
NA |
22 |
NA |
NA |
NA |
NA |
6 |
NA |
GSM50130 | NA |
Basal |
IBE |
WID |
ICR3 |
400003185 |
B6-T |
DistantMetastasisFree |
3.36 |
DiseaseFree |
NA |
NA |
54 |
NA |
ER- |
PR- |
NA |
3 |
T2 |
BoneMetastasisFree |
3.36 |
LungMetastasisFree |
23 |
NA |
3.36 |
3+ |
3.36 |
18 |
Bad Prognosis |
GSM50131 | NA |
LumB |
IBD |
FID |
ICR3 |
400003186 |
B8-T |
DistantMetastasis |
4.59 |
Recurred/Progressed |
NA |
NA |
42 |
NA |
ER+ |
PR+ |
NA |
3.9 |
T2 |
BoneMetastasis |
4.59 |
LungMetastasisFree |
28 |
1 |
4.59 |
N |
6.05 |
24 |
Bad Prognosis |
GSM50132 | NA |
NA |
NA |
NA |
NA |
400003187 |
B9-T |
NA |
NA |
NA |
NA |
NA |
74 |
NA |
ER+ |
PR- |
NA |
3.9 |
T2 |
NA |
NA |
NA |
31 |
NA |
NA |
N |
NA |
29 |
NA |
Name | ||
---|---|---|
All Samples | Default | View |
Immune Benefit Status | View | |
Immunological Constant of Rejection | View | |
Molecular Subtype | View | |
Pathology T Stage | View | |
In order to make new Group Sets or change settings, please log in. |
Group Set | |
---|---|
All Samples | |
Immune Benefit Status | |
Immunological Constant of Rejection | |
Molecular Subtype | |
Pathology T Stage |